Rhythm Pharmaceuticals, Inc. reports earnings inline with expectations. Reported EPS is $-0.7 EPS, expectations were $-0.7. Rhythm Pharmaceuticals, Inc.
Share:
New York, Feb. 23, 2021 (GLOBE NEWSWIRE) Reportlinker.com announces the release of the report Cell Therapy Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Therapy Type ; Product ; Technology ; Application ; End User, and Geography - https://www.reportlinker.com/p06027528/?utm source=GNW However, the high cost of cell therapy manufacturing hinders the growth of the market.
Cell therapy is a procedure where living and intact cells are injected, implanted, or grafted into the patient s body.This technology relies on replacing dysfunctional cells with healthy functioning ones.
Cells mainly used for such advanced therapies are stem cells, as they have ability to differentiate into the specific cells required for repairing damaged or defective tissues or cells. Moreover, cell therapy has applications in the development of regenerative medicines.